淋巴细胞白血病-话题@MedSci

#淋巴细胞白血病#

277篇内容 | 4747人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1997822, encodeId=6271199e8228b, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NEJM：利妥昔单抗可延长B细胞急性淋巴细胞白血病患者生存期, objectType=article, longId=77709, objectId=5f4ae770963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f4ae770963, replyNumber=0, likeNumber=61, createdTime=2017-04-07, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f4ae770963, moduleTitle=NEJM：利妥昔单抗可延长B细胞急性淋巴细胞白血病患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f4ae770963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997809, encodeId=4a0b199e80990, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NEJM：Acalabrutinib有望治疗慢性淋巴细胞白血病（CLL）患者, objectType=article, longId=61694, objectId=eb9d6169425, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb9d6169425, replyNumber=0, likeNumber=65, createdTime=2016-12-10, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb9d6169425, moduleTitle=NEJM：Acalabrutinib有望治疗慢性淋巴细胞白血病（CLL）患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb9d6169425)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997824, encodeId=2611199e824f0, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2015NICE技术评估指南——Idelalisib治疗慢性淋巴细胞白血病（TA359）发布, objectType=article, longId=79984, objectId=9181e99846e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9181e99846e, replyNumber=0, likeNumber=34, createdTime=2016-12-27, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9181e99846e, moduleTitle=2015NICE技术评估指南——Idelalisib治疗慢性淋巴细胞白血病（TA359）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9181e99846e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997812, encodeId=7e6c199e812d1, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=5个适应证！FDA批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）, objectType=article, longId=64673, objectId=6448646e38c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6448646e38c, replyNumber=0, likeNumber=75, createdTime=2016-12-23, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6448646e38c, moduleTitle=5个适应证！FDA批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6448646e38c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997814, encodeId=99f8199e81414, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=FDA授予安进BiTE免疫疗法Blincyto治疗儿科急性淋巴细胞白血病（ALL）的优先审查资格, objectType=article, longId=67544, objectId=c7dd6e544b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7dd6e544b6, replyNumber=0, likeNumber=65, createdTime=2017-03-20, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7dd6e544b6, moduleTitle=FDA授予安进BiTE免疫疗法Blincyto治疗儿科急性淋巴细胞白血病（ALL）的优先审查资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7dd6e544b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997808, encodeId=51b4199e80800, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=英国医生采用基因编辑CART细胞成功治愈1岁急性淋巴细胞白血病婴儿, objectType=article, longId=58488, objectId=a89f58488c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a89f58488c2, replyNumber=0, likeNumber=79, createdTime=2015-12-07, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a89f58488c2, moduleTitle=英国医生采用基因编辑CART细胞成功治愈1岁急性淋巴细胞白血病婴儿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a89f58488c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997813, encodeId=c4fb199e81369, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=JCI：CAR-T细胞治疗对复发或难治性急性B淋巴细胞白血病有神奇效果！, objectType=article, longId=67349, objectId=89f06e34900, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89f06e34900, replyNumber=0, likeNumber=104, createdTime=2017-03-15, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89f06e34900, moduleTitle=JCI：CAR-T细胞治疗对复发或难治性急性B淋巴细胞白血病有神奇效果！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89f06e34900)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997810, encodeId=80b6199e810d5, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Lancet Haematol：阿伦单抗治疗T细胞大颗粒淋巴细胞白血病的安全性和有效性, objectType=article, longId=62503, objectId=ae97625036d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae97625036d, replyNumber=0, likeNumber=70, createdTime=2016-08-27, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae97625036d, moduleTitle=Lancet Haematol：阿伦单抗治疗T细胞大颗粒淋巴细胞白血病的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae97625036d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997815, encodeId=9e66199e81565, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=内免疫疗法的信心！我国生物技术公司ICT CAR-T治疗B淋巴细胞白血病治愈率达90%, objectType=article, longId=67957, objectId=792e6e95716, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=792e6e95716, replyNumber=0, likeNumber=56, createdTime=2016-06-20, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=792e6e95716, moduleTitle=内免疫疗法的信心！我国生物技术公司ICT CAR-T治疗B淋巴细胞白血病治愈率达90%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=792e6e95716)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997811, encodeId=ee60199e811c0, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Lancet Haematol：选择剖宫产，后代患急性淋巴细胞白血病(ALL)的风险增加, objectType=article, longId=63906, objectId=33686390658, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33686390658, replyNumber=0, likeNumber=67, createdTime=2016-03-25, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33686390658, moduleTitle=Lancet Haematol：选择剖宫产，后代患急性淋巴细胞白血病(ALL)的风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33686390658)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997805, encodeId=c141199e80529, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=ONF：急性淋巴细胞白血病（ALL）患儿体重的肥胖/超重率如何改变？, objectType=article, longId=52895, objectId=3f71528958c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f71528958c, replyNumber=0, likeNumber=86, createdTime=2016-03-21, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f71528958c, moduleTitle=ONF：急性淋巴细胞白血病（ALL）患儿体重的肥胖/超重率如何改变？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f71528958c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997806, encodeId=ed32199e80650, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Lancet Oncol：Ofatumumab维持治疗慢性淋巴细胞白血病效果, objectType=article, longId=56169, objectId=2193561692f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2193561692f, replyNumber=0, likeNumber=64, createdTime=2016-03-24, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2193561692f, moduleTitle=Lancet Oncol：Ofatumumab维持治疗慢性淋巴细胞白血病效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2193561692f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997804, encodeId=abfb199e8043f, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Clin Cancer Res：Ibrutinib治疗能抑制BTK和VLA-4依赖粘附的慢性淋巴细胞白血病, objectType=article, longId=52412, objectId=edd55241231, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edd55241231, replyNumber=0, likeNumber=55, createdTime=2015-12-18, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edd55241231, moduleTitle=Clin Cancer Res：Ibrutinib治疗能抑制BTK和VLA-4依赖粘附的慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edd55241231)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997807, encodeId=00c7199e80763, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Sci Transl Med：CAR-T对难治或复发性慢性淋巴细胞白血病疗效显著, objectType=article, longId=56369, objectId=958e5636923, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=958e5636923, replyNumber=0, likeNumber=74, createdTime=2016-06-05, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=958e5636923, moduleTitle=Sci Transl Med：CAR-T对难治或复发性慢性淋巴细胞白血病疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=958e5636923)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997803, encodeId=3b92199e8030b, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Nat Med：中国学者破解儿童急性淋巴细胞白血病复发难题, objectType=article, longId=50771, objectId=c09550e7101, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c09550e7101, replyNumber=0, likeNumber=65, createdTime=2015-12-30, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c09550e7101, moduleTitle=Nat Med：中国学者破解儿童急性淋巴细胞白血病复发难题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c09550e7101)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997801, encodeId=6c2e199e8013f, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Oncology Nursing Forum：急性淋巴细胞白血病患儿及其母亲睡眠质量堪忧, objectType=article, longId=44429, objectId=b1644442913, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1644442913, replyNumber=0, likeNumber=59, createdTime=2015-10-27, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1644442913, moduleTitle=Oncology Nursing Forum：急性淋巴细胞白血病患儿及其母亲睡眠质量堪忧, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1644442913)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997802, encodeId=b389199e80274, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=JAMA Oncology：依鲁替尼胶囊在治疗慢性淋巴细胞白血病（CLL）终止的原因, objectType=article, longId=47609, objectId=f9504e60953, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9504e60953, replyNumber=0, likeNumber=62, createdTime=2015-10-20, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9504e60953, moduleTitle=JAMA Oncology：依鲁替尼胶囊在治疗慢性淋巴细胞白血病（CLL）终止的原因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9504e60953)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997800, encodeId=41a4199e800fd, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=ASH 2014：安进BiTE免疫疗法Blincyto有效治疗急性淋巴细胞白血病（ALL）, objectType=article, longId=43800, objectId=5ccf43800e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ccf43800e2, replyNumber=0, likeNumber=63, createdTime=2015-01-20, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ccf43800e2, moduleTitle=ASH 2014：安进BiTE免疫疗法Blincyto有效治疗急性淋巴细胞白血病（ALL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ccf43800e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997795, encodeId=103c199e79599, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=FDA批准Gazyva与苯丁酸氮芥联合治疗慢性淋巴细胞白血病, objectType=article, longId=26357, objectId=0aed2635ee7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0aed2635ee7, replyNumber=0, likeNumber=78, createdTime=2014-08-18, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0aed2635ee7, moduleTitle=FDA批准Gazyva与苯丁酸氮芥联合治疗慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0aed2635ee7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997798, encodeId=f0cd199e79863, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Nat Gene：科学家揭示急性淋巴细胞白血病的幕后推手, objectType=article, longId=29378, objectId=157a293e857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=157a293e857, replyNumber=0, likeNumber=64, createdTime=2014-02-28, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=157a293e857, moduleTitle=Nat Gene：科学家揭示急性淋巴细胞白血病的幕后推手, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=157a293e857)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞白血病

2020-05-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NEJM：利妥昔单抗可延长B细胞急性淋巴细胞白血病患者生存期

2017-04-07

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NEJM：Acalabrutinib有望治疗慢性淋巴细胞白血病（CLL）患者

2016-12-10

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2015NICE技术评估指南——Idelalisib治疗慢性淋巴细胞白血病（TA359）发布

2016-12-27

仁心济世 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

5个适应证！FDA批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）

2016-12-23

仁者大医 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

FDA授予安进BiTE免疫疗法Blincyto治疗儿科急性淋巴细胞白血病（ALL）的优先审查资格

2017-03-20

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

英国医生采用基因编辑CART细胞成功治愈1岁急性淋巴细胞白血病婴儿

2015-12-07

仁者大医 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

JCI：CAR-T细胞治疗对复发或难治性急性B淋巴细胞白血病有神奇效果！

2017-03-15

仁者大医 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Lancet Haematol：阿伦单抗治疗T细胞大颗粒淋巴细胞白血病的安全性和有效性

2016-08-27

仁者大医 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

内免疫疗法的信心！我国生物技术公司ICT CAR-T治疗B淋巴细胞白血病治愈率达90%

2016-06-20

仁者大医 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Lancet Haematol：选择剖宫产，后代患急性淋巴细胞白血病(ALL)的风险增加

2016-03-25

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

ONF：急性淋巴细胞白血病（ALL）患儿体重的肥胖/超重率如何改变？

2016-03-21

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Lancet Oncol：Ofatumumab维持治疗慢性淋巴细胞白血病效果

2016-03-24

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Clin Cancer Res：Ibrutinib治疗能抑制BTK和VLA-4依赖粘附的慢性淋巴细胞白血病

2015-12-18

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Sci Transl Med：CAR-T对难治或复发性慢性淋巴细胞白血病疗效显著

2016-06-05

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Nat Med：中国学者破解儿童急性淋巴细胞白血病复发难题

2015-12-30

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Oncology Nursing Forum：急性淋巴细胞白血病患儿及其母亲睡眠质量堪忧

2015-10-27

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

JAMA Oncology：依鲁替尼胶囊在治疗慢性淋巴细胞白血病（CLL）终止的原因

2015-10-20

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

ASH 2014：安进BiTE免疫疗法Blincyto有效治疗急性淋巴细胞白血病（ALL）

2015-01-20

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

FDA批准Gazyva与苯丁酸氮芥联合治疗慢性淋巴细胞白血病

2014-08-18

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Nat Gene：科学家揭示急性淋巴细胞白血病的幕后推手

2014-02-28

科室
- - 订阅+
  - 更多科室
工具
服务